{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:48:30Z","timestamp":1781531310801,"version":"3.54.5"},"reference-count":29,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2017,12,6]]},"DOI":"10.3233\/cbm-170157","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T12:12:25Z","timestamp":1505823145000},"page":"411-415","source":"Crossref","is-referenced-by-count":36,"title":["Pioglitazone suppresses inflammation and fibrosis in nonalcoholic fatty liver disease by down-regulating PDGF and TIMP-2: Evidence from in vitro study"],"prefix":"10.1177","volume":"20","author":[{"given":"Wen","family":"Deng","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Yantaishan Hospital, Yantai 264000, Shandong, China"},{"name":"Department of Cardiovascular Medicine, Yantaishan Hospital, Yantai 264000, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimin","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Weihai Municipal Hospital, Weihai 264200, Shandong, China"},{"name":"Department of Cardiovascular Medicine, Yantaishan Hospital, Yantai 264000, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitao","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Digestive, Yantaishan Hospital, Yantai 264000, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Digestive, Yantaishan Hospital, Yantai 264000, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/CBM-170157_ref1","doi-asserted-by":"crossref","unstructured":"Non Alcoholic Fatty Liver Disease Study and Lonardo Group, et al., Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups, Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 47 (2015), 997\u20131006.","DOI":"10.1016\/j.dld.2015.08.004"},{"key":"10.3233\/CBM-170157_ref2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.3233\/CBM-170157_ref3","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease","volume":"65","author":"Fazel","year":"2016","journal-title":"Metabolism: Clinical and Experimental"},{"key":"10.3233\/CBM-170157_ref4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12325-016-0306-9","article-title":"The role of nuclear receptors in the pathophysiology, natural course, and drug treatment of NAFLD in humans","volume":"33","author":"Ballestri","year":"2016","journal-title":"Advances in Therapy"},{"key":"10.3233\/CBM-170157_ref5","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3748\/wjg.v23.i8.1458","article-title":"Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis","volume":"23","author":"Rinaldi","year":"2017","journal-title":"World Journal of Gastroenterology"},{"key":"10.3233\/CBM-170157_ref6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.28368","article-title":"Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study","volume":"63","author":"Piscaglia","year":"2016","journal-title":"Hepatology"},{"key":"10.3233\/CBM-170157_ref7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jcmgh.2015.07.007","article-title":"Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-gamma","volume":"1","author":"Povero","year":"2015","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"key":"10.3233\/CBM-170157_ref8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00125-015-3769-3","article-title":"Circulating leptin in non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"59","author":"Polyzos","year":"2016","journal-title":"Diabetologia"},{"key":"10.3233\/CBM-170157_ref9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.dld.2017.01.147","article-title":"Association for the Study of the, AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions","volume":"49","author":"Italian","year":"2017","journal-title":"Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"key":"10.3233\/CBM-170157_ref10","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome, Evidence from a systematic review and meta-analysis","volume":"31","author":"Ballestri","year":"2016","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.3233\/CBM-170157_ref11","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/hepr.12656","article-title":"The independent predictors of non-alcoholic steatohepatitis and its individual histological features: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment","volume":"46","author":"Ballestri","year":"2016","journal-title":"Hepatology Research: The Official Journal of the Japan Society of Hepatology"},{"key":"10.3233\/CBM-170157_ref12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbalip.2007.04.016","article-title":"PPARs in the brain","volume":"1771","author":"Heneka","year":"2007","journal-title":"Biochimica Et Biophysica Acta"},{"key":"10.3233\/CBM-170157_ref13","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.2174\/138920012803762765","article-title":"Hepatic steatosis and peroxisomal fatty acid beta-oxidation","volume":"13","author":"Cherkaoui-Malki","year":"2012","journal-title":"Current Drug Metabolism"},{"key":"10.3233\/CBM-170157_ref14","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3748\/wjg.v10.i9.1329","article-title":"Peroxisome proliferator activated receptor-gamma in pathogenesis of experimental fatty liver disease","volume":"10","author":"Zhao","year":"2004","journal-title":"World Journal of Gastroenterology"},{"key":"10.3233\/CBM-170157_ref15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/hep.21661","article-title":"The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis","volume":"46","author":"Lutchman","year":"2007","journal-title":"Hepatology"},{"key":"10.3233\/CBM-170157_ref16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/00365520802530861","article-title":"Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice","volume":"44","author":"Nan","year":"2009","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.3233\/CBM-170157_ref17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bcp.2015.11.026","article-title":"Pioglitazone, a PPARgamma agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR\/p70S6K and ERK signaling","volume":"101","author":"Osman","year":"2016","journal-title":"Biochemical Pharmacology"},{"key":"10.3233\/CBM-170157_ref18","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/hep.27999","article-title":"Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis","volume":"62","author":"Singh","year":"2015","journal-title":"Hepatology"},{"key":"10.3233\/CBM-170157_ref19","doi-asserted-by":"crossref","first-page":"e4529","DOI":"10.1097\/MD.0000000000004529","article-title":"Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis","volume":"95","author":"Sawangjit","year":"2016","journal-title":"Medicine"},{"key":"10.3233\/CBM-170157_ref20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1902\/jop.1995.66.7.552","article-title":"Growth factor effects on the expression of collagenase and TIMP-1 in periodontal ligament cells","volume":"66","author":"Alvares","year":"1995","journal-title":"Journal of Periodontology"},{"key":"10.3233\/CBM-170157_ref21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1053\/jhep.2002.32483","article-title":"Nonalcoholic fatty liver disease: An agenda for clinical research","volume":"35","author":"Younossi","year":"2002","journal-title":"Hepatology"},{"key":"10.3233\/CBM-170157_ref22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0028-1091978","article-title":"The epidemiology of nonalcoholic fatty liver disease: A global perspective","volume":"28","author":"Lazo","year":"2008","journal-title":"Seminars in Liver Disease"},{"key":"10.3233\/CBM-170157_ref23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"key":"10.3233\/CBM-170157_ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7555\/JBR.27.20120077","article-title":"Lipoprotein metabolism in nonalcoholic fatty liver disease","volume":"27","author":"Jiang","year":"2013","journal-title":"Journal of Biomedical Research"},{"key":"10.3233\/CBM-170157_ref25","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"10.3233\/CBM-170157_ref26","first-page":"2316","article-title":"Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats","volume":"125","author":"Zhao","year":"2012","journal-title":"Chinese Medical Journal"},{"key":"10.3233\/CBM-170157_ref27","doi-asserted-by":"crossref","first-page":"18070","DOI":"10.3748\/wjg.v20.i48.18070","article-title":"Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease","volume":"20","author":"Stojsavljevic","year":"2014","journal-title":"World Journal of Gastroenterology"},{"key":"10.3233\/CBM-170157_ref28","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2337\/dc16-0798","article-title":"Pioglitazone prevents diabetes in patients with insulin resistance and cerebrovascular disease","volume":"39","author":"Inzucchi","year":"2016","journal-title":"Diabetes Care"},{"key":"10.3233\/CBM-170157_ref29","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/hep.1840380427","article-title":"Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone","volume":"38","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-170157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:05:30Z","timestamp":1777385130000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-170157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,6]]},"references-count":29,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/cbm-170157","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12,6]]}}}